Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Breast Neoplasms 3Ovarian Neoplasms 2Neoplasm Metastasis 2Glioblastoma 2Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Renal Insufficiency 1Primary Myelofibrosis 1Polycythemia Vera 1Pancreatic Neoplasms 1Neoplasms, Unknown Primary 1Myelodysplastic-Myeloproliferative Diseases 1Melanoma 1Lung Neoplasms 1Liver Failure 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Transitional Cell 1Astrocytoma 1Ann Arbor Stage III Non-Hodgkin Lymphoma 1Advanced Malignant Solid Neoplasm 1

Interventions

ruxolitinib 9navitoclax 4Tacrolimus 4Cyclophosphamide 4Whole-Body Irradiation 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3venetoclax 2fludarabine phosphate 2fludarabine 2Melphalan 2Busulfan 2veliparib 1selinexor 1pevonedistat 1luspatercept 1letermovir 1itacitinib 1imetelstat 1givinostat hydrochloride 1givinostat 1fedratinib 1elotuzumab 1canakinumab 1avelumab 1Valganciclovir 1Topotecan 1Therapeutics 1Stem Cell Transplantation 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Primary Myelofibrosis × veliparib × Clear all
NCT03289910 2026-04-13

Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
25 enrolled 15 charts
MyeloidOther hematologic neoplasm

Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡